A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis

While rare, serious adverse effects including euglycemic diabetic ketoacidosis (EDKA) have been associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. We present an interesting case of SGLT2i-induced EDKA occurring two years after initiation of therapy. Most patients with EDKA recove...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Shiavax J, Kumar, Kaushik, Saleh, Nahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643074/
https://www.ncbi.nlm.nih.gov/pubmed/36381906
http://dx.doi.org/10.7759/cureus.30106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643074/
https://www.ncbi.nlm.nih.gov/pubmed/36381906
http://dx.doi.org/10.7759/cureus.30106

Ejemplares similares